S H Kelkar & Company Ltd
S H Kelkar and Company Limited is engaged in manufacture, supply and exports of fragrances and aroma ingredients[1] It is the largest domestic fragrance producer in India and the only company of Indian origin to file patents in the field of Fragrance & Novel aroma molecules.
- Market Cap ₹ 3,373 Cr.
- Current Price ₹ 244
- High / Low ₹ 336 / 142
- Stock P/E 59.4
- Book Value ₹ 53.0
- Dividend Yield 0.31 %
- ROCE 7.54 %
- ROE 7.61 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 4.60 times its book value
- The company has delivered a poor sales growth of 9.61% over past five years.
- Company has a low return on equity of 10.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
399 | 471 | 559 | 615 | 682 | 694 | 719 | 761 | 807 | 880 | 941 | 1,137 | |
317 | 405 | 466 | 514 | 579 | 629 | 646 | 661 | 722 | 754 | 806 | 1,055 | |
Operating Profit | 81 | 66 | 93 | 101 | 103 | 65 | 73 | 100 | 85 | 125 | 134 | 82 |
OPM % | 20% | 14% | 17% | 16% | 15% | 9% | 10% | 13% | 11% | 14% | 14% | 7% |
3 | 32 | 24 | 11 | 14 | 19 | 10 | 34 | 13 | -16 | 21 | -55 | |
Interest | 15 | 13 | 14 | 3 | 3 | 7 | 12 | 6 | 4 | 5 | 7 | 19 |
Depreciation | 13 | 15 | 13 | 7 | 11 | 15 | 28 | 28 | 28 | 27 | 26 | 26 |
Profit before tax | 57 | 70 | 89 | 103 | 103 | 62 | 43 | 100 | 66 | 77 | 123 | -18 |
Tax % | 23% | 12% | 26% | 28% | 33% | 28% | 26% | 20% | 36% | 32% | 23% | -27% |
44 | 62 | 66 | 74 | 69 | 45 | 32 | 80 | 42 | 52 | 94 | -14 | |
EPS in Rs | 3,316.70 | 4.66 | 4.54 | 5.14 | 4.77 | 3.11 | 2.26 | 5.64 | 3.07 | 3.77 | 6.81 | -0.98 |
Dividend Payout % | 34% | 23% | 33% | 34% | 37% | 0% | 42% | 31% | 24% | 53% | 11% | -102% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 12% |
TTM: | 21% |
Compounded Profit Growth | |
---|---|
10 Years: | 1% |
5 Years: | 13% |
3 Years: | 10% |
TTM: | -40% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 23% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 10% |
3 Years: | 11% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 |
Reserves | 256 | 168 | 401 | 474 | 483 | 452 | 427 | 494 | 463 | 504 | 620 | 595 |
119 | 154 | 0 | 1 | 19 | 87 | 76 | 67 | 47 | 95 | 83 | 326 | |
107 | 100 | 114 | 140 | 207 | 207 | 298 | 329 | 370 | 347 | 359 | 380 | |
Total Liabilities | 495 | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 | 1,439 |
104 | 94 | 93 | 114 | 154 | 201 | 254 | 222 | 224 | 202 | 186 | 197 | |
CWIP | 0 | 0 | 0 | 5 | 18 | 24 | 13 | 17 | 3 | 8 | 6 | 16 |
Investments | 98 | 99 | 167 | 220 | 269 | 269 | 253 | 321 | 322 | 311 | 343 | 502 |
293 | 361 | 400 | 421 | 412 | 397 | 422 | 472 | 470 | 565 | 666 | 724 | |
Total Assets | 495 | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 | 1,439 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | 21 | 45 | 67 | 118 | 105 | 187 | 84 | 84 | -11 | 30 | -13 | |
-30 | 26 | -57 | -92 | -88 | -87 | -32 | -65 | 10 | -24 | -20 | -178 | |
10 | 0 | 3 | -3 | -49 | -13 | -124 | -24 | -116 | 33 | 4 | 182 | |
Net Cash Flow | -9 | 47 | -9 | -28 | -19 | 5 | 31 | -5 | -21 | -3 | 14 | -8 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 76 | 59 | 75 | 82 | 100 | 66 | 74 | 96 | 73 | 59 | 66 | 52 |
Inventory Days | 273 | 244 | 217 | 198 | 147 | 164 | 147 | 136 | 185 | 239 | 269 | 182 |
Days Payable | 113 | 65 | 94 | 71 | 131 | 127 | 199 | 211 | 234 | 193 | 192 | 147 |
Cash Conversion Cycle | 236 | 238 | 198 | 209 | 117 | 103 | 23 | 21 | 25 | 104 | 143 | 88 |
Working Capital Days | 133 | 142 | 151 | 160 | 109 | 98 | 33 | 49 | 35 | 76 | 100 | 96 |
ROCE % | 19% | 17% | 21% | 18% | 17% | 10% | 8% | 16% | 10% | 15% | 16% | 8% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Submission of Annual Secretarial Compliance Report for FY ended March 31, 2025.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
27 May - Transcript of the conference call for investors and analysts on the Q4FY25 results.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22 May - Audio recording of Q4 & FY25 results conference call available on company website.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Newspaper publications in respect of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2025
- Submission Of Earnings Presentation And Press Release In Respect Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2025 16 May
Annual reports
Concalls
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020TranscriptPPT
-
Sep 2020Transcript PPT
-
Jul 2020TranscriptPPT
-
May 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Dec 2018Transcript PPT
-
Sep 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Jan 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Oct 2017TranscriptNotesPPT
-
Sep 2017Transcript PPT
-
Jun 2017TranscriptPPT
-
Mar 2017Transcript PPT
-
Nov 2016Transcript PPT
-
Sep 2016TranscriptPPT
-
Aug 2016TranscriptNotesPPT
-
Jun 2016Transcript PPT
-
Mar 2016TranscriptPPT
Product Portfolio
Fragrances - Personal care, Hair care, Skin care & cosmetics, fabric care, House products, etc.
Flavors - Food applications format, High-performance formats, etc...
Services - Biotechnology research service, Cosmetic research services, custom synthesis service. [1]
Co. offers products under the SHK, Cobra, Auris, Wheel, Three Birds and Keva brands. In FY23, the Fragrance segment remained the primary revenue contributor with ~87% share[2].The company has about 9700+SKUs.[3]